Brennan, B J <br/><br/>
The pharmacokinetics of peginterferon alfa-2a and ribavirin in African American, Hispanic and Caucasian patients with chronic hepatitis C.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  May 2012 
 - 1209-20 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2012.05079.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Black or African American--genetics<br/>Antiviral Agents--administration & dosage<br/>Area Under Curve<br/>Clinical Trials as Topic<br/>Dose-Response Relationship, Drug<br/>Female<br/>Genotype<br/>Hepatitis C, Chronic--drug therapy<br/>Hispanic or Latino--genetics<br/>Humans<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Polyethylene Glycols--administration & dosage<br/>Recombinant Proteins--administration & dosage<br/>Ribavirin--administration & dosage<br/>White People--genetics